Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Nov 19;21(1):229.
doi: 10.1186/s12881-020-01175-y.

Overwhelming sepsis in a neonate affected by Zellweger syndrome due to a compound heterozygosis in PEX 6 gene: a case report

Affiliations
Case Reports

Overwhelming sepsis in a neonate affected by Zellweger syndrome due to a compound heterozygosis in PEX 6 gene: a case report

Laura Lucaccioni et al. BMC Med Genet. .

Abstract

Background: Peroxisome biogenesis disorders (PBDs) are a group of metabolic diseases caused by dysfunction of peroxisomes. Different forms of PBDs are described; the most severe one is the Zellweger syndrome (ZS). We report on an unusual presentation of Zellweger syndrome manifesting in a newborn with severe and fulminant sepsis, causing death during the neonatal period.

Case presentation: A term male Caucasian neonate presented at birth with hypotonia and poor feeding associated with dysmorphic craniofacial features and skeletal abnormalities. Blood tests showed progressive leukopenia; ultrasounds revealed cerebral and renal abnormalities. He died on the fourth day of life because of an irreversible Gram-negative sepsis. Post-mortem tests on blood and urine samples showed biochemical alterations suggestive of ZS confirmed by genetic test.

Conclusions: ZS is an early and severe forms of PBDs. Peroxisomes are known to be involved in lipid metabolism, but recent studies suggest their fundamental role in modulating immune response and inflammation. In case of clinical suspicion of ZS it is important to focus the attention on the prevention and management of infections that can rapidly progress to death.

Keywords: Innate immunity; Peroxisome biogenesis disorders; Very long chain fatty acids; Zellweger syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Cerebral Ultrasound images A: coronal posterior scan shows hyperechoic subcortical white matter; B: lateral sagittal scan shows ventricular pseudocysts and linear hyperechoic striae in basal ganglia

References

    1. Braverman NE, Raymond GV, Rizzo WB, Moser AB, Wilkinson ME, Stone EM, et al. Peroxisome biogenesis disorders in the Zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines. Mol Genet Metab. 2016;117:313–321. doi: 10.1016/j.ymgme.2015.12.009. - DOI - PMC - PubMed
    1. Lee PR, Raymond GV. Child neurology: Zellweger syndrome. Neurology. 2013;14:e207–e210. doi: 10.1212/WNL.0b013e3182929f8e. - DOI - PMC - PubMed
    1. Rafique M, Zia S, Rana MN, Ossama MA. Zellweger syndrome — a lethal peroxisome biogenesis disorder. J Pediatr Endocr Met. 2013;26:377–379. - PubMed
    1. Waterham HR, Ferdinandusse S, Wanders RJ. Human disorders of peroxisome metabolism and biogenesis. Biochim Biophys Acta. 1863;2016:923–933. - PubMed
    1. Klouwer FCC, Berendse K, Ferdinandusse S, Wanders RJA, Engelen M, Tien P-TB. Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis. 2015;10:151. doi: 10.1186/s13023-015-0368-9. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances